Previous Close | 8.50 |
Open | 8.50 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 8.34 - 8.79 |
52 Week Range | 3.21 - 10.69 |
Volume | |
Avg. Volume | 89,858 |
Market Cap | 127.617M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.79 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.50 |
Key Insights The considerable ownership by retail investors in Coya Therapeutics indicates that they collectively have...
Performance Misses Analyst Estimates Amidst Expanding Clinical Pipeline
HOUSTON, May 09, 2024--Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a corporate update and announces its financial results for the quarter ended March 31, 2024.